Transvaginal mesh lawsuit settlement amounts have ranged from approximately $40,000 to $450,000 per claimant, with strong claims in 2025 reaching $400,000 to $900,000. Across all manufacturers, more than $8 billion has been paid to claimants in 48 states, making this one of the largest mass tort litigations in U.S. history. The average settlement from Boston Scientific has been approximately $53,000 per claimant, while Johnson & Johnson’s Ethicon division has averaged around $59,000 per claimant.
For context, Susan McFarland received a $120 million jury verdict against Ethicon in 2019″”the highest single verdict in these cases””though most women receive far less through negotiated settlements. Over 100,000 women nationwide have filed lawsuits against mesh manufacturers, and approximately 95% of these cases have been resolved through settlements or jury verdicts as of December 2025. The remaining cases continue through litigation, with discovery deadlines extended to June 30, 2026, for ongoing matters. This article examines the specific settlement amounts by manufacturer, factors that influence individual payouts, the current status of litigation, and what women considering legal action should understand about the process.
Table of Contents
- How Much Are Transvaginal Mesh Lawsuit Settlements Worth?
- Major Manufacturer Settlement Amounts and Payouts
- What Factors Determine Individual Settlement Amounts?
- Current Status of Transvaginal Mesh Litigation in 2026
- How the MDL Settlement Process Affects Compensation
- Warning Signs and Timing for Filing Claims
- Looking Ahead: What the Future Holds for Mesh Litigation
- Conclusion
How Much Are Transvaginal Mesh Lawsuit Settlements Worth?
Individual settlement amounts in transvaginal mesh cases depend heavily on injury severity, the number of revision surgeries required, and which manufacturer produced the device. Women who required multiple corrective procedures or experienced permanent complications typically receive higher compensation than those with less severe outcomes. The $40,000 to $450,000 range represents the majority of settlements, but outliers exist on both ends. Jury verdicts have ranged from $25 million to over $120 million in bellwether trials””test cases used to gauge how juries respond to the evidence. However, these headline-grabbing numbers rarely reflect what individual claimants actually receive.
Most cases settle before trial, and the amounts are negotiated based on the strength of medical evidence, documented complications, and the manufacturer’s overall settlement strategy. johnson & Johnson, for example, paid $302 million in a California judgment that was ultimately upheld by the U.S. Supreme Court, demonstrating that manufacturers have faced both negotiated settlements and court-ordered judgments. A critical distinction exists between standalone cases and those consolidated in multidistrict litigation (MDL). Women whose cases were handled individually, outside the MDL process, have generally secured higher settlements than those whose claims were grouped with thousands of others. This difference reflects the leverage individual plaintiffs can maintain when they are not part of mass settlement negotiations.
Major Manufacturer Settlement Amounts and Payouts
American Medical Systems, once the largest pelvic mesh manufacturer, has paid the most in total settlements. The company agreed to $830 million to resolve 20,000 claims in 2014. Its parent company, Endo International, later set aside an additional $775 million for 22,000 claims in 2017. All told, American Medical Systems has spent approximately $2.6 billion on mesh-related settlements””more than any other manufacturer. Boston Scientific has faced substantial liability across multiple fronts. The company paid $119 million to settle approximately 3,000 lawsuits in April 2015.
In 2021, Boston Scientific agreed to a $189 million multistate settlement with 47 state attorneys general, including $8.8 million specifically to Washington State. The company also paid $105 million to settle an Australian class-action lawsuit in March 2023, demonstrating that mesh litigation has extended beyond U.S. borders. Johnson & Johnson’s Ethicon division has paid $120 million to settle approximately 3,000 claims in January 2016, plus $9.9 million to Kentucky in February 2023. The $302 million California judgment, which survived appeals all the way to the Supreme Court, stands as one of the largest single manufacturer liabilities in these cases. However, if you were harmed by an Ethicon device but have mild complications with no revision surgery, your individual settlement would likely fall toward the lower end of the $40,000 to $450,000 range rather than approaching the higher figures seen in severe cases.
What Factors Determine Individual Settlement Amounts?
The severity of complications is the primary driver of settlement value. Women who experienced mesh erosion, organ perforation, chronic infections, or nerve damage requiring multiple surgeries typically receive higher compensation. Those who underwent mesh removal or revision procedures””sometimes multiple times””can document their injuries more concretely, which translates to stronger settlement positions. Medical records play a decisive role. Clear documentation linking the mesh device to specific complications, treatment dates, and ongoing symptoms provides the evidence necessary to negotiate higher settlements.
Women whose medical histories include pre-existing conditions or other factors that defendants can attribute symptoms to may face challenges in establishing causation. This is why legal experts emphasize obtaining complete medical records before pursuing claims. The timing of claims also matters. Early participants in MDL settlements often received different amounts than later claimants as manufacturers adjusted their settlement strategies. Women filing new cases in 2025 and 2026, particularly those with documented delayed complications, may have different opportunities than those who settled years earlier. Four new pelvic mesh cases against Ethicon recently joined litigation in New Jersey with discovery just beginning, showing that the litigation remains active for newly discovered injuries.
Current Status of Transvaginal Mesh Litigation in 2026
As of January 2026, transvaginal mesh litigation continues despite approximately 95% of cases being resolved. The discovery deadline for ongoing cases has been extended to June 30, 2026, giving plaintiffs additional time to gather evidence. New cases continue to be filed as women experience delayed complications””mesh erosion and chronic pain sometimes develop years after implantation, meaning the statute of limitations may not have expired for women only now discovering their injuries. International litigation has also progressed. Approximately 140 women in England recently reached an undisclosed settlement with Johnson & Johnson, Boston Scientific, and Bard.
While the specific amounts were not made public, this settlement signals that manufacturers continue resolving claims globally rather than fighting extended legal battles. For women considering whether to pursue claims, the current landscape offers both opportunities and limitations. Standalone cases””those pursued individually rather than consolidated in mass litigation””have yielded higher settlements than MDL-consolidated cases. However, individual litigation is more resource-intensive and requires attorneys willing to invest significant time in a single case. Women with severe, well-documented complications are the strongest candidates for standalone approaches.
How the MDL Settlement Process Affects Compensation
Multidistrict litigation consolidates similar cases before a single judge to streamline pretrial proceedings. While this process is more efficient than thousands of individual trials, it creates a dynamic where settlement amounts are negotiated en masse rather than individually. Manufacturers calculate total settlement funds based on the number of claims and average severity, then allocate amounts using predetermined criteria. The bellwether trial process within MDLs has produced dramatic jury verdicts””$25 million to $120 million””but these serve primarily as negotiating benchmarks rather than payouts individual claimants receive.
When juries award large verdicts against manufacturers, it increases pressure to settle remaining cases at higher values. Conversely, defense verdicts reduce settlement leverage for plaintiffs. Women in MDL settlements typically receive less than those with comparable injuries who pursued standalone litigation. The tradeoff is speed and certainty: MDL settlements resolve cases in months or a few years, while individual litigation can take five years or longer. For older plaintiffs or those with urgent financial needs, the faster resolution of MDL settlements may outweigh the potentially higher recovery of standalone cases.
Warning Signs and Timing for Filing Claims
Transvaginal mesh complications can emerge years after implantation. Common symptoms include chronic pelvic pain, pain during intercourse, mesh erosion through vaginal tissue, urinary problems, and infections. Women who experience these symptoms should consult both a physician and a legal professional to determine whether their complications may be device-related. Statutes of limitations vary by state and typically begin running when the injury is discovered or reasonably should have been discovered.
This “discovery rule” is particularly important for mesh cases because complications often develop gradually. A woman who had mesh implanted in 2015 but only experienced erosion in 2024 may still have viable claims depending on her state’s laws. For example, a woman in Texas who discovers mesh erosion in 2025 would need to file within two years under that state’s statute of limitations, while a woman in Kentucky would have only one year. Consulting an attorney promptly after discovering complications is essential to preserve legal rights.
Looking Ahead: What the Future Holds for Mesh Litigation
The transvaginal mesh litigation is entering its final phase, but will not conclude quickly. With discovery in new cases extending through June 2026 and women continuing to discover delayed complications, new filings will persist for years. Manufacturers have largely shifted from contesting liability to managing settlement costs, but cases with particularly severe injuries or novel legal theories may still proceed to trial.
For women who have not yet filed claims, the window is narrowing but not closed. Those experiencing mesh-related complications should document symptoms thoroughly, preserve all medical records, and consult with attorneys experienced in device litigation. The difference between a $40,000 settlement and a $400,000 settlement often comes down to the quality of evidence and the expertise of legal representation.
Conclusion
Transvaginal mesh lawsuit settlements have totaled more than $8 billion across all manufacturers, with individual payouts ranging from $40,000 to $450,000 depending on injury severity and case circumstances. American Medical Systems, Boston Scientific, and Johnson & Johnson’s Ethicon division have all paid hundreds of millions””in some cases billions””to resolve claims from over 100,000 women nationwide. Jury verdicts in bellwether trials have reached as high as $120 million, though most claimants receive far less through negotiated settlements.
Women currently experiencing mesh complications should act promptly to explore their legal options. The litigation remains active with discovery extended through June 2026, and new cases continue to be filed. Those with severe, well-documented injuries and quality legal representation have secured settlements at the higher end of the range, while cases with less documentation or milder symptoms have settled for lower amounts. Consulting with an experienced attorney is the essential first step in understanding what an individual case may be worth.